Literature DB >> 2997997

Effect of tunicamycin and monensin on biosynthesis, transport, and maturation of bovine herpesvirus type-1 glycoproteins.

S van Drunen Littel-van den Hurk, L A Babiuk.   

Abstract

The effect of tunicamycin and monensin on the biosynthesis, intracellular transport, and maturation of bovine herpesvirus type-1 (BHV-1) glycoproteins was examined. Tunicamycin completely inhibited the production of infectious virus particles and significantly reduced the incorporation of [3H]glucosamine into viral glycoproteins. In the presence of monensin, reduced amounts of infectious virus particles were produced, which was mainly due to inhibition of virus release, rather than virus production. Monensin only slightly inhibited viral glycoprotein synthesis. The effects of these compounds on infectivity indicated that glycosylation is required for the production of infectious virus, though complete processing of the glycoproteins is not essential. In addition, egress of the virions from infected cells probably requires a functional Golgi complex. In the presence of tunicamycin or monensin various degrees of glycosylation of the major glycoproteins occurred, consequently their rates of migration differed from that of the normal glycoproteins. Tunicamycin completely blocked glycosylation of GVP 6/11a/16 and GVP 7. In contrast, GVP 3/9 and GVP 11b were partially glycosylated in the presence of tunicamycin. These results indicated that GVP 6/11a/16 and GVP 7 are N-linked glycoproteins, but GVP 3/9 and GVP 11b contain both N- and O-linked oligosaccharide side chains. Tunicamycin blocked the transport of all viral glycoproteins to the cell surface, suggesting that glycosylation is required for this process. In the presence of monensin, the viral glycoproteins were transported and expressed on the cell surface indicating that transport does not require complete processing of the glycoproteins and may occur via a Golgi-independent pathway. In addition, monensin-treated BHV-1 infected cells could act as target cells in an antibody-dependent cell cytotoxicity assay. Thus, complete glycosylation may not be essential for maintenance of antigenicity and participation in immune destruction.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2997997      PMCID: PMC7130974          DOI: 10.1016/0042-6822(85)90100-x

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  54 in total

1.  Inhibition of Rous sarcoma virus replication by 2-deoxyglucose and tunicamycin: identification of an unglycosylated env gene product.

Authors:  R Stohrer; E Hunter
Journal:  J Virol       Date:  1979-11       Impact factor: 5.103

2.  Herpes simplex virus glycoproteins: participation of individual herpes simplex virus type 1 glycoprotein antigens in immunocytolysis and their correlation with previously identified glycopolypeptides.

Authors:  B Norrild; S L Shore; A J Nahmias
Journal:  J Virol       Date:  1979-12       Impact factor: 5.103

Review 3.  The role of polyprenol-linked sugars in glycoprotein synthesis.

Authors:  C J Waechter; W J Lennarz
Journal:  Annu Rev Biochem       Date:  1976       Impact factor: 23.643

Review 4.  Biological applications of ionophores.

Authors:  B C Pressman
Journal:  Annu Rev Biochem       Date:  1976       Impact factor: 23.643

5.  Effect of tunicamycin on the synthesis of herpes simplex virus type 1 glycoproteins and their expression on the cell surface.

Authors:  B Norrild; B Pedersen
Journal:  J Virol       Date:  1982-08       Impact factor: 5.103

6.  Biogenesis of vaccinia: carbohydrate of the hemagglutinin molecules.

Authors:  H Shida; S Dales
Journal:  Virology       Date:  1981-05       Impact factor: 3.616

7.  Herpesvirus-induced "early" glycoprotein: characterization and possible role in immune cytolysis.

Authors:  V Misra; J E Gilchrist; G Weinmaster; L Qualtiere; S Van den Hurk; L A Babiuk
Journal:  J Virol       Date:  1982-09       Impact factor: 5.103

8.  Herpesvirus glycoprotein synthesis and insertion into plasma membranes.

Authors:  M L Peake; P Nystrom; L I Pizer
Journal:  J Virol       Date:  1982-05       Impact factor: 5.103

9.  O-glycosidic carbohydrate-peptide linkages of Herpes simplex virus glycoproteins.

Authors:  S Olofsson; J Blomberg; E Lycke
Journal:  Arch Virol       Date:  1981       Impact factor: 2.574

10.  Differential effect of monensin on enveloped viruses that form at distinct plasma membrane domains.

Authors:  F V Alonso; R W Compans
Journal:  J Cell Biol       Date:  1981-06       Impact factor: 10.539

View more
  20 in total

1.  Bovine herpesvirus type 1 gp87 mediates both attachment of virions to susceptible cells and hemagglutination.

Authors:  K Okazaki; E Honda; T Minetoma; T Kumagai
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

2.  Gene mapping of infectious bovine rhinotracheitis viral DNA genome.

Authors:  C Simard; F Nadon; C Séguin; S LaBoissière; M Trudel
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

3.  Synthesis and processing of bovine herpesvirus 1 glycoproteins.

Authors:  S van Drunen Littel-van den Hurk; L A Babiuk
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

4.  Herpes simplex virus type 1 capsids transit by the trans-Golgi network, where viral glycoproteins accumulate independently of capsid egress.

Authors:  Sophie Turcotte; Josée Letellier; Roger Lippé
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

5.  Temporal control of bovine herpesvirus 1 glycoprotein synthesis.

Authors:  G V Ludwig; G J Letchworth
Journal:  J Virol       Date:  1987-10       Impact factor: 5.103

6.  Intracellular localization and transport of three different bovine herpesvirus type 1 glycoproteins involved in neutralization.

Authors:  K Okazaki; H Kawakura; M Okada; E Honda; T Minetoma; T Kumagai
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

7.  Polypeptide specificity of the antibody response after primary and recurrent infection with bovine herpesvirus 1.

Authors:  S van Drunen Littel-van den Hurk; L A Babiuk
Journal:  J Clin Microbiol       Date:  1986-02       Impact factor: 5.948

8.  Processing of the gp55-116 envelope glycoprotein complex (gB) of human cytomegalovirus.

Authors:  W J Britt; L G Vugler
Journal:  J Virol       Date:  1989-01       Impact factor: 5.103

9.  Synthesis, cellular location, and immunogenicity of bovine herpesvirus 1 glycoproteins gI and gIII expressed by recombinant vaccinia virus.

Authors:  S van Drunen Littel-van den Hurk; T Zamb; L A Babiuk
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

10.  Role of N-linked glycans in antigenicity, processing, and cell surface expression of bovine herpesvirus 1 glycoprotein gIV.

Authors:  S K Tikoo; M D Parker; J V van den Hurk; J Kowalski; T J Zamb; L A Babiuk
Journal:  J Virol       Date:  1993-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.